Inotiv Reveals Preliminary Q4 And FY2025 Revenue, Stock Jumps

Shares of Inotiv, Inc. (NOTV) jumped more than 23% in overnight trading after the company released preliminary results for its fiscal fourth quarter and full year ended September 30, 2025.The Indiana-based contract research organization, known for its nonclinical drug discovery and development services, expects Q4, 2025 revenue in the range of $137.5 million to $138.5 million, compared to $130.4 million in the prior year's fourth quarter - an increase of roughly 6% year-over-year.For the full fiscal year 2 ...